AI-aided Medical Image Analytics for Early Cancer Screening

Overview

ASTRI has been developing an AI-aided medical image analytics system for collaborative diagnosis, image management, lesion detection, and classification in pathology images and capsule endoscopy videos. This technology can help doctors improve diagnosis and work efficiency.

  • AI-aided Medical Image Analytics for Early Cancer Screening 0
  • AI-aided Medical Image Analytics for Early Cancer Screening 1
Technical name of innovation
Smart doctor assistant for early cancer screening through medical image analysis
Research completion
2018 and 2019
Commercialisation opportunities
IP licensing -Technology co-development
Problem addressed

•Medical image analysis is very time-consuming for doctors

•Impossible for doctors to analyze all collected medical images 

•Images with unobvious features are easily overlooked by doctors with inadequate experience

•Medical diagnosis is location-restricted

Innovation

The medical image analytics system includes:

-Lesion detection for ultra-long (several hours) video analysis of capsule endoscopes 

-Malignant cell screening for digitalized whole slide (file size reaches several GB) cervical pathological image

Image enhancement, video summary and location segmentation for system performance improvement 

Model design and optimization for accuracy improvement and processing speed acceleration.

-Unified platform management for ease of use.

Key impact
  • AI-aided medical image analytics system can work 24 hours a day
  • AI processing and analysis speed far exceeds doctor's manual analysis
  • The medical image analytics system can be continuously improved and optimized
  • AI-assisted medical image analysis system can be used as a mentor for junior doctors
Application

AI-aided

-Malignant cell detection in pathology image

-Lesion detection and cancer identification in endoscopy video

Patent

  • US Patent No. 10,586,336 and CN App. No. 201880000830.0
  • US Patent No. 10,354,122 and CN Patent No. ZL201880000218.3
  • US Patent No. 10,937,158 and CN App. No. 201980001954.5
  • US Patent No. 11,270,447; CN App. No. 202080000389.3 and HK App. No. 62021023136.6
Hong Kong Applied Science and Technology Research Institute (ASTRI)

Hong Kong Applied Science and Technology Research Institute (ASTRI) is founded in 2000 by the Government of the Hong Kong Special Administrative Region. As Hong Kong’s largest government-funded research and development centre, ASTRI is a key force and super connector driving innovation and technology advancement in Hong Kong, the Greater Bay Area, and the global innovation ecosystem. This role is strengthened through its merger with Nano and Advanced Materials Institute (NAMI).

Committed to bringing high impact research from lab to market, ASTRI advances interdisciplinary, market driven R&D that delivers practical innovations for industry and meaningful benefits for society.

Enquiry
Related Innovations